文献
J-GLOBAL ID:202102248566094744
整理番号:21A0902547
後天性オラパリブ耐性BRCA1変異体卵巣細胞に対する治療戦略としてのATRまたはChk1阻害剤と併用したオラパリブ【JST・京大機械翻訳】
Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells
著者 (7件):
Burgess Brian T.
(Division of Gynecologic Oncology, Department of OB/GYN, University of Kentucky, Whitney-Hendrickson Building, 800 Rose Street, Lexington, KY 40536, USA)
,
Anderson Abigail M.
(Markey Cancer Center, University of Kentucky, 789 South Limestone Street, 526 Todd Building, Lexington, KY 40536, USA)
,
McCorkle J. Robert
(Markey Cancer Center, University of Kentucky, 789 South Limestone Street, 526 Todd Building, Lexington, KY 40536, USA)
,
Wu Jianrong
(Biostatistics and Bioinformatics Shared Resource Facility, University of Kentucky, 800 Rose Street, Roach Building CC433, Lexington, KY 40536, USA)
,
Ueland Frederick R.
(Division of Gynecologic Oncology, Department of OB/GYN, University of Kentucky, Whitney-Hendrickson Building, 800 Rose Street, Lexington, KY 40536, USA)
,
Kolesar Jill M.
(Markey Cancer Center, University of Kentucky, 789 South Limestone Street, 526 Todd Building, Lexington, KY 40536, USA)
,
Kolesar Jill M.
(College of Pharmacy, University of Kentucky, 567 Todd Building, 789 South Limestone Street, Lexington, KY 40536, USA)
資料名:
Diagnostics (Web)
(Diagnostics (Web))
巻:
10
号:
2
ページ:
121
発行年:
2020年
JST資料番号:
U7173A
ISSN:
2075-4418
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
スイス (CHE)
言語:
英語 (EN)